RIGEL PHARMACEUTICALS INC's ticker is RIGL and the CUSIP is 766559603. A total of 140 filers reported holding RIGEL PHARMACEUTICALS INC in Q3 2022. The put-call ratio across all filers is 0.10 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $30,000 | +50.0% | 26,998 | +66.9% | 0.00% | – |
Q2 2023 | $20,000 | -81.0% | 16,179 | -79.6% | 0.00% | – |
Q1 2023 | $105,000 | -71.4% | 79,167 | -67.6% | 0.00% | – |
Q4 2022 | $367,000 | +230.6% | 244,037 | +160.5% | 0.00% | – |
Q3 2022 | $111,000 | +1750.0% | 93,665 | +1763.6% | 0.00% | – |
Q2 2022 | $6,000 | -87.0% | 5,026 | -67.6% | 0.00% | – |
Q1 2022 | $46,000 | -59.3% | 15,498 | -63.5% | 0.00% | – |
Q4 2021 | $113,000 | +37.8% | 42,424 | +88.3% | 0.00% | – |
Q3 2021 | $82,000 | +15.5% | 22,533 | +39.1% | 0.00% | – |
Q2 2021 | $71,000 | +18.3% | 16,198 | -8.8% | 0.00% | – |
Q1 2021 | $60,000 | +2900.0% | 17,761 | +1809.8% | 0.00% | – |
Q3 2020 | $2,000 | -91.7% | 930 | -92.8% | 0.00% | – |
Q2 2020 | $24,000 | -46.7% | 12,933 | -55.9% | 0.00% | – |
Q1 2020 | $45,000 | +1400.0% | 29,347 | +1850.0% | 0.00% | – |
Q4 2019 | $3,000 | 0.0% | 1,505 | +0.3% | 0.00% | – |
Q3 2019 | $3,000 | -25.0% | 1,500 | -1.4% | 0.00% | – |
Q2 2019 | $4,000 | 0.0% | 1,522 | +0.1% | 0.00% | – |
Q1 2019 | $4,000 | -20.0% | 1,521 | -39.2% | 0.00% | – |
Q4 2018 | $5,000 | -66.7% | 2,500 | -47.0% | 0.00% | – |
Q3 2018 | $15,000 | +114.3% | 4,714 | +88.6% | 0.00% | – |
Q2 2018 | $7,000 | -22.2% | 2,500 | 0.0% | 0.00% | – |
Q1 2018 | $9,000 | -10.0% | 2,500 | -3.1% | 0.00% | – |
Q4 2017 | $10,000 | -63.0% | 2,580 | -76.2% | 0.00% | – |
Q3 2017 | $27,000 | +2600.0% | 10,824 | +3092.9% | 0.00% | – |
Q2 2017 | $1,000 | -93.8% | 339 | -93.0% | 0.00% | – |
Q1 2017 | $16,000 | +33.3% | 4,851 | -2.2% | 0.00% | – |
Q4 2016 | $12,000 | +500.0% | 4,961 | +892.2% | 0.00% | – |
Q3 2016 | $2,000 | 0.0% | 500 | -30.7% | 0.00% | – |
Q2 2016 | $2,000 | 0.0% | 722 | -12.2% | 0.00% | – |
Q1 2016 | $2,000 | -33.3% | 822 | -13.4% | 0.00% | – |
Q4 2015 | $3,000 | -75.0% | 949 | -80.6% | 0.00% | – |
Q3 2015 | $12,000 | -36.8% | 4,899 | -15.7% | 0.00% | – |
Q2 2015 | $19,000 | +1800.0% | 5,809 | +1924.0% | 0.00% | – |
Q1 2015 | $1,000 | 0.0% | 287 | +29.3% | 0.00% | – |
Q4 2014 | $1,000 | – | 222 | 0.0% | 0.00% | – |
Q3 2014 | $0 | -100.0% | 222 | 0.0% | 0.00% | – |
Q2 2014 | $1,000 | 0.0% | 222 | 0.0% | 0.00% | – |
Q1 2014 | $1,000 | 0.0% | 222 | 0.0% | 0.00% | – |
Q4 2013 | $1,000 | -96.6% | 222 | -97.2% | 0.00% | – |
Q3 2013 | $29,000 | -38.3% | 8,021 | -43.0% | 0.00% | – |
Q2 2013 | $47,000 | – | 14,075 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Tamarack Advisers, LP | 4,500,000 | $11,925,000 | 4.90% |
HealthInvest Partners AB | 1,090,000 | $2,889,000 | 4.07% |
GREAT POINT PARTNERS LLC | 5,000,000 | $13,250,000 | 2.94% |
CM Management, LLC | 775,000 | $2,054,000 | 1.55% |
SECTOR GAMMA AS | 1,469,604 | $3,894,000 | 0.92% |
Sio Capital Management, LLC | 913,621 | $2,421,000 | 0.73% |
Telemetry Investments, L.L.C. | 190,000 | $504,000 | 0.65% |
DAFNA Capital Management LLC | 879,000 | $2,329,000 | 0.59% |
Rock Springs Capital Management LP | 4,860,200 | $12,880,000 | 0.30% |
Rhenman & Partners Asset Management AB | 1,520,000 | $4,074,000 | 0.27% |